Review




Structured Review

Invitae Inc multigene panel
Multigene Panel, supplied by Invitae Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hereditary+cancer+solution+hcs+ce+ivd+multigene+panel/cancer+invitae+multi+panel/pm40737716-46-3-15
Average 86 stars, based on 1 article reviews
multigene panel - by Bioz Stars, 2026-09
86/100 stars

Images

Related Articles

Mutagenesis:

Article Title: Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial
Article Snippet: .. Baseline germline mutation testing was performed at trial screening using the Invitae Common Hereditary Cancers Panel (48 genes) or the Invitae Multi-Cancer Panel (70 genes). ..

Article Title: Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial.
Article Snippet: .. Baseline germline mutation testing was performed at trial screening using the Invitae Common Hereditary Cancers Panel (48 genes) or the Invitae Multi-Cancer Panel (70 genes). ..

Next-Generation Sequencing:

Article Title: Erdheim-Chester disease mimicking Wilms tumor in a child: a diagnostic challenge.
Article Snippet: .. Given the multisystem involvement, extensive molecular genetic testing was performed using a next-generation sequencing (NGS)–based multigene panel (“INVITAE” laboratory, San Francisco, CA, United States; 27 July 2022), which included sequencing and deletion/duplication analysis of 2,782 genes associated with neurocutaneous and multisystem disorders, including neurofibromatosis types 1 and 2 and tuberous sclerosis complex. ..

Sequencing:

Article Title: Erdheim-Chester disease mimicking Wilms tumor in a child: a diagnostic challenge.
Article Snippet: .. Given the multisystem involvement, extensive molecular genetic testing was performed using a next-generation sequencing (NGS)–based multigene panel (“INVITAE” laboratory, San Francisco, CA, United States; 27 July 2022), which included sequencing and deletion/duplication analysis of 2,782 genes associated with neurocutaneous and multisystem disorders, including neurofibromatosis types 1 and 2 and tuberous sclerosis complex. ..

Article Title: Case Report: An uncommon germline variant of familial GISTs: broadening the landscape of inherited GIST syndromes
Article Snippet: .. Germline testing with Invitae Multi-Cancer + RNA 70 gene panel was performed, and the patient was determined to be heterozygous for the c.1735_1737del (p.Asp579del) pathogenic variant KIT (sequence identifier NM_000222.2 ). ..

Variant Assay:

Article Title: Case Report: An uncommon germline variant of familial GISTs: broadening the landscape of inherited GIST syndromes
Article Snippet: .. Germline testing with Invitae Multi-Cancer + RNA 70 gene panel was performed, and the patient was determined to be heterozygous for the c.1735_1737del (p.Asp579del) pathogenic variant KIT (sequence identifier NM_000222.2 ). ..

other:




Similar Products

97
Sophia Genetics hereditary cancer solution hcs ce ivd multigene panel
Hereditary Cancer Solution Hcs Ce Ivd Multigene Panel, supplied by Sophia Genetics, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hereditary+cancer+solution+hcs+ce+ivd+multigene+panel/Hereditary+cancers/pmc12650687-77-6-14
Average 97 stars, based on 1 article reviews
hereditary cancer solution hcs ce ivd multigene panel - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

Image Search Results